{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:51:02Z","timestamp":1789732262424,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T00:00:00Z","timestamp":1187136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s12033-007-0072-7","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T16:08:36Z","timestamp":1187107716000},"page":"33-40","source":"Crossref","is-referenced-by-count":82,"title":["Cell Adhesion Molecules: Potential Therapeutic & Diagnostic Implications"],"prefix":"10.1007","volume":"38","author":[{"given":"Shaker A.","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"issue":"2","key":"72_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/med.2610140203","volume":"14","author":"D. Cox","year":"1994","unstructured":"Cox, D., Aoki, T., Seki, J., Motoyama, Y., & Yoshida, K. (1994). The pharmacology of the integrins. Medicinal Research Reviews, 14(2), 195\u2013228.","journal-title":"Medicinal Research Reviews"},{"key":"72_CR2","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1096\/fasebj.4.11.2199285","volume":"4","author":"S. M. Albelda","year":"1990","unstructured":"Albelda, S. M., & Buck, C. A. (1990). Integrins and other cell adhesion molecules. The FASEB Journal, 4, 2868\u20132880.","journal-title":"The FASEB Journal"},{"issue":"2","key":"72_CR3","first-page":"135","volume":"19","author":"N. S. Cook","year":"1994","unstructured":"Cook, N. S., Kottirsch, G., & Zerwes, H. (1994). Platelet glycoprotein IIb\/IIIa antagonists. Drugs Future, 19(2), 135\u2013159.","journal-title":"Drugs Future"},{"key":"72_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI114757","volume":"86","author":"H. Gold","year":"1990","unstructured":"Gold, H., Gimple, L. W., & Yasuda, T., et al. (1990). Pharmacodynamic study of F(ab\u2019)2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb\/IIIa in patients with unstable angina pectoris. The Journal of Clinical Investigation, 86, 651\u2013659.","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"72_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ajh.20801","volume":"82","author":"S. A. Mousa","year":"2007","unstructured":"Mousa, S. A., & Ahmad, S. (2007). Platelet GPIIb\/IIIa antagonist, XV459, in heparin-induced thrombocytopenia. American Journal of Hematology, 82(4), 276\u2013282.","journal-title":"American Journal of Hematology"},{"key":"72_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000175994","volume":"83","author":"S. A. Mousa","year":"1993","unstructured":"Mousa, S. A., Bozarth, J. M., & Forsythe, M. S., et al. (1993). Anti-platelet efficacy and specificity of DMP 728, a novel platelet GPIIb\/IIIa receptor antagonist. Cardiology, 83, 374\u2013382.","journal-title":"Cardiology"},{"issue":"1","key":"72_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.CIR.89.1.3","volume":"89","author":"S. A. Mousa","year":"1994","unstructured":"Mousa, S. A., Bozarth, J. M., & Forsythe, M. S., et al. (1994). Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb\/IIIa receptor antagonist. Circulation, 89(1), 3\u201312.","journal-title":"Circulation"},{"key":"72_CR8","unstructured":"Mousa, S. A., & Topol, E. (1997). Novel antiplatelet therapies: Recent advances. In Patrick, W., Serruys, & David Holmes (Ed.), The development of platelet GPIIb\/IIIa receptor antagonists. Current Review of Interventional Cardiology (3rd ed., vol. 13, pp. 114\u2013129). Philadelphia, PA: Current Medicine."},{"key":"72_CR9","doi-asserted-by":"crossref","unstructured":"Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994). Requirement of vascular integrin \u03b1v\u03b23 for angiogenesis. Science, 264, 569\u2013571.","DOI":"10.1126\/science.7512751"},{"key":"72_CR10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"P. C. Brooks","year":"1994","unstructured":"Brooks, P. C., Montgomery, A. M. P., & Rosenfield, M., et al. (1994). Integrin \u03b1v\u03b23 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157\u20131164.","journal-title":"Cell"},{"key":"72_CR11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0092-8674(90)90487-Y","volume":"63","author":"B Brandley","year":"1990","unstructured":"Brandley, B, Swiedler, S., & Rabbins, P. (1990). Carbohydrate ligands for the LEC cell adhesion molecules. Cell, 63, 861\u2013863.","journal-title":"Cell"},{"key":"72_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0092-8674(92)90612-G","volume":"69","author":"L. A. Lasky","year":"1992","unstructured":"Lasky, L. A., Singer, M., & Dowbenko, D., et al. (1992). An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell, 69, 927\u2013938.","journal-title":"Cell"},{"key":"72_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.1439808","volume":"258","author":"L. A. Lasky","year":"1992","unstructured":"Lasky, L. A. (1992). Selectins: Interproteins of cell-specific carboyhdrate information during inflammation. Science, 258, 964\u2013968.","journal-title":"Science"},{"key":"72_CR14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.1701274","volume":"250","author":"M. L. Phillips","year":"1990","unstructured":"Phillips, M. L., Nudelman, E., & Gaeta, F. A., et al. (1990). ELAM-1 mediate cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science, 250, 1130\u20131132.","journal-title":"Science"},{"key":"72_CR15","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI116501","volume":"91","author":"A. S. Weyrich","year":"1993","unstructured":"Weyrich, A. S., Ma, X.-L., Leter, D. J., Albertine, K. H., & Lefer, A. M. (1993). In\u00a0vivo neutralization of P-selectin protects Feline heart and endothelium in myocardial ischemia and reperfusion injury. The Journal of Clinical Investigation, 91, 2620\u20132629.","journal-title":"The Journal of Clinical Investigation"},{"key":"72_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/364149a0","volume":"364","author":"M. S. Mulligan","year":"1993","unstructured":"Mulligan, M. S., Paulson, J. C., & De Frees, S., et al. (1993). Protective effects of oligo-saccharides in P-selectin -dependent lung injury. Nature, 364, 149\u2013151.","journal-title":"Nature"},{"key":"72_CR17","first-page":"4897","volume":"9","author":"T. G. Hullinger","year":"1995","unstructured":"Hullinger, T. G., De Graaf, G. L., Hartman, J. C., & Shebuski, R. J. (1995). The effect of P-selectin blockade on neointimal lesion development in a primate carotid injury model. FASEB, 9, 4897.","journal-title":"FASEB"},{"key":"72_CR18","unstructured":"Paulson, J. C. (1992). Selectin\/carbohydrate-mediated adhesion of leukocytes. In J. M. Harlan, & D. Y. Liu (Ed.), Adhesion: Its role in inflammatory disease. Chapter 2 (pp. 19\u201342). W.H. Freeman and Company."},{"key":"72_CR19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(94)90007-8","volume":"343","author":"E. J. Topol","year":"1994","unstructured":"Topol, E. J., Califf, R. M., & Weisman, H. F., et al. (1994). Randomized trial of coronary intervention with antibody against platelet IIb\/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet, 343, 881\u2013886.","journal-title":"Lancet"},{"key":"72_CR20","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","volume":"152","author":"A. Hamann","year":"1994","unstructured":"Hamann, A., Andrew, D. P., Jablonski-Westrich, D., Holzmann, B., & Butcher, E. C. (1994). Role of \u03b14-integrins in lymphocyte homing to mucosal tissues in\u00a0vivo. Journal of Immunology, 152, 3282\u20133293.","journal-title":"Journal of Immunology"},{"key":"72_CR21","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.147.12.4178","volume":"147","author":"T. B. Issekutz","year":"1991","unstructured":"Issekutz, T. B. (1991). Inhibition of in\u00a0vivo lymphocyte migration to inflammation and homing to lymphoid tissues by TA-2 monoclonal antibody. Journal of Immunology, 147, 4178\u20134184.","journal-title":"Journal of Immunology"},{"key":"72_CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(90)90661-W","volume":"60","author":"M. J. Elices","year":"1990","unstructured":"Elices, M. J., Osborn, L., & Takada, Y., et al. (1990). VCAM-1 on activated endothelium interacts with leukocyte integrin VLA-4 at asite distinct from the VLA-4\/fibronectin binding site. Cell, 60, 577\u2013578.","journal-title":"Cell"},{"key":"72_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","volume":"74","author":"C. Berlin","year":"1994","unstructured":"Berlin, C., Berg, E. L., Briskin, M. J., & Andrew, D. P., et al. (1994). \u03b14\u03b27 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell, 74, 185\u2013195.","journal-title":"Cell"},{"key":"72_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"T. A. Yednock","year":"1992","unstructured":"Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992). Prevention of experimental autoimmune encephalomyelitis by antibodies against \u03b14\u03b21 integrin. Nature, 356, 63\u201366.","journal-title":"Nature"},{"key":"72_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"T. A. Springer","year":"1994","unstructured":"Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration. The multistep paradigm. Cell, 76, 301\u2013314.","journal-title":"Cell"},{"key":"72_CR26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","volume":"37","author":"B. Cannella","year":"1995","unstructured":"Cannella, B., & Raine, C. S. (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Annals of Neurology, 37, 424\u2013435.","journal-title":"Annals of Neurology"},{"key":"72_CR27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/eji.1830170910","volume":"17","author":"N. Cerf-Bensussan","year":"1987","unstructured":"Cerf-Bensussan, N., Jarry, A., & Lisowska-Grospierre, B., et al. (1987). A monoclonal (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. European Journal of Immunology, 17, 1279\u20131285.","journal-title":"European Journal of Immunology"},{"key":"72_CR28","unstructured":"Varner, J., Mousa, S. A. (1998). Antagonists of vascular cell integrin \u03b15\u03b21 inhibit angiogenesis. Circulation, 98(Suppl. I), I-795, 4166."},{"issue":"6","key":"72_CR29","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1073\/pnas.050587897","volume":"97","author":"D Cue","year":"2000","unstructured":"Cue D, Southern, S., Southern, P., Jadhav, P. K., Lorelli, W., Smallheer, J., Mousa, S., & Cleary, P. (2000). A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of streptococcus pyogenes by blocking formation of integrin \u03b15\u03b21 \u2013fibronectin \u2013M1 protein complex. Proceedings of the National Academy of Sciences, 97(6), 2858\u20132863.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"72_CR30","unstructured":"Figdor, C. G., & Kooyk, Y. V. (1992). Regulation of cell adhesion. In J. M. Harlan, & D. Y. Liu (Ed.), Chapter 7 (pp. 151\u2013182). W.H. Freeman and Company."},{"key":"72_CR31","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","volume":"90","author":"J. E. Tcheng","year":"1994","unstructured":"Tcheng, J. E., Ellis, S. G., & George, B. S., et al. (1994). Pharmacodynamics of chimeric glycoprotein IIb\/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation, 90, 1757\u20131764.","journal-title":"Circulation"},{"key":"72_CR32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"EPIC Investigators","year":"1994","unstructured":"EPIC Investigators. (1994). Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. The New England Journal of Medicine, 330, 956\u2013961.","journal-title":"The New England Journal of Medicine"},{"key":"72_CR33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0735-1097(93)90041-X","volume":"22","author":"N. S. Kleiman","year":"1993","unstructured":"Kleiman, N. S., Ohman, E., & Califf, R. M., et al. (1993). Profound inhibition of platelet aggregation with monoclonal antibody 73E Fab after thrombolytic therapy: Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study. Journal of the American College of Cardiology, 22, 381\u20139.","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"72_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.91.8.2151","volume":"91","author":"J. E. Tcheng","year":"1995","unstructured":"Tcheng, J. E., Harrington, R. A., & Kottke-Marchant K., et al. (1995). Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb\/IIIa blocker, Integrilin in elective coronary intervention. IMPACT Investigators. Circulation, 91(8), 215\u2013217.","journal-title":"Circulation"},{"issue":"4 pt 1","key":"72_CR35","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.88.4.1512","volume":"88","author":"K. Peerlinck","year":"1993","unstructured":"Peerlinck, K., De Lepeleire, I., & Goldberg, M., et al. (1993). MK383 (L-700462), a selective nonpeptide platelet glycoprotein IIb\/IIIa antagonist, is active in man. Circulation, 88(4 pt 1), 1512\u20131517.","journal-title":"Circulation"},{"key":"72_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.90.1.1","volume":"90","author":"P. Th\u00e9roux","year":"1994","unstructured":"Th\u00e9roux, P., Kouz, S., & Knudtson, M. L., et al. (1994). A randomized double-blind controlled trial with the non-peptide platelet GPIIb\/IIIa antagonist RO 44\u20139883 in unstable angina [abstract]. Circulation, 90, 1\u2013232.","journal-title":"Circulation"},{"key":"72_CR37","unstructured":"Kottke-Marchant, K., Simpfendorfer, C., Lowrie, M., Burns, D., & Anders, R. J. (1995). Sustained but variable inhibition of platelet aggregation with Xemilofiban, an oral GPIIb\/IIIa receptor antagonist, in patients with unstable angina. Circulation, 92(8 Suppl.), I-488."},{"issue":"4","key":"72_CR38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.96.4.1130","volume":"96","author":"T. H. Muller","year":"1997","unstructured":"Muller, T. H., Weisenberger, H., Brickl, R., Narjes, H., Himmelsbach, F., & Krause, J (1997). Profound and sustained inhibition of platelet aggregation by Fradafiban, nonpeptide platelet glycoprotein IIb\/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men. Circulation, 96(4), 1130\u20131138.","journal-title":"Circulation"},{"issue":"4","key":"72_CR39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.CIR.97.4.340","volume":"97","author":"C. P. Cannon","year":"1998","unstructured":"Cannon, C. P., McCabe, C. H., Borzak, S., Henry, T. D., Tischler, M. D., Mueller, H. S., Feldman, R., & Palmeri, S. T., et al. (1998). Randomized trial of an oral platelet glycoprotein IIb\/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in myocardial infarction. Circulation, 97(4), 340\u2013349.","journal-title":"Circulation"},{"issue":"1","key":"72_CR40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1527-3466.1998.tb00344.x","volume":"16","author":"S. A. Mousa","year":"1998","unstructured":"Mousa, S. A., & Wityak, J. (1998). Orally active Isoxazoline GPIIb\/IIIa antagonists. Cardiovascular Drug Reviews, 16(1), 48\u201361.","journal-title":"Cardiovascular Drug Reviews"},{"key":"72_CR41","unstructured":"Harrington, R. A., Graffagnino, C., Armstrong, P. W., Joseph, D., & Card, T. L., et al. (1998). Dose-finding and tolerability of a new oral platelet GPIIb\/IIIa inhibitor, SB 214857, in patients with coronary artery and cerebrovascular disease: The APLAUD results. Circulation, 98(17 suppl.), I-251, P 1303."},{"issue":"4","key":"72_CR42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.CIR.97.4.312","volume":"97","author":"D. A. Vorchheimer","year":"1998","unstructured":"Vorchheimer, D. A., & Fuster, V. (1998). Oral platelet glycoprotein IIb\/IIIa receptor antagonists: the present challenge is safety [editorial; comment]. Circulation, 97(4), 312\u2013314.","journal-title":"Circulation"},{"issue":"5 Pt 2 Su","key":"72_CR43","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0002-8703(98)70239-X","volume":"135","author":"M. Quinn","year":"1998","unstructured":"Quinn, M., & Fitzgerald, D. J. (1998). Long-term administration of glycoprotein IIb\/IIIa antagonists. American Heart Journal, 135(5 Pt 2 Su), S113\u2013S118.","journal-title":"American Heart Journal"},{"issue":"2\/3","key":"72_CR44","first-page":"1","volume":"9","author":"S. Mousa","year":"1998","unstructured":"Mousa, S., Bozarth, J., Edward, S., Carroll, T., & Barrett, J. (1998). Novel Technetium-99m Labelled Platelet GPIIb\/IIIa Receptor Antagonists For Imaging Venous & Arterial Thrombosis. Coronary Artery Disease, 9(2\/3), 1\u201311.","journal-title":"Coronary Artery Disease"},{"key":"72_CR45","unstructured":"Srivasata, S., Reilly, T., Shwartz, R., Holmes, D., & Mousa, S. (1996). Selective \u03b1v\u03b23 integrin blockade limits neointima hyperplasia and lumen stenosis in stented porcine coronary artery injury in Pig. Circulation, 94(8), I-41, 0231 (abst.)."},{"key":"72_CR46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/excr.1994.1282","volume":"214","author":"T.-L. Yue","year":"1994","unstructured":"Yue, T.-L., McKenna, P. J., & Ohlstein, E. H., et al. (1994). Osteopontin-stimulated vascular smooth muscle cell migration is mediated by \u03b23 integrin. Experimental Cell Research, 214, 459\u2013464.","journal-title":"Experimental Cell Research"},{"key":"72_CR47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI117718","volume":"95","author":"L. Liaw","year":"1995","unstructured":"Liaw, L., Skiner, M. P., & Raines, E. W., et al. (1995). The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. The Journal of Clinical Investigation, 95, 713\u2013724.","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"72_CR48","first-page":"1505","volume":"94","author":"R. Zee","year":"1996","unstructured":"Zee, R., Passeri, J., Barry, J., Cheresh, D., & Isner, J. (1996). A neutralizing antibody to the alpha v Beta 3 integrin reduces neointimal thickening in a balloon-injured iliac artery. Circulation, 94(8), 1505 (abst.).","journal-title":"Circulation"},{"key":"72_CR49","first-page":"533","volume":"23","author":"T. Flavin","year":"1991","unstructured":"Flavin, T., Rothlein, R., Faanes, R., Ivens, K., & Starnes, V. A. (1991). Monoclonal antibody against intercellular adhesion molecule (ICAM)-1 prolongs cardiac allograft survival in cynomologus monkey. Transplantation Proceedings, 23, 533\u2013534.","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"72_CR50","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00007890-199304000-00016","volume":"55","author":"C. E. Haug","year":"1993","unstructured":"Haug, C. E., Colvin, R. B., & Delmonico, F. L., et al. (1993). A phase I trial of immunosuppressant with anti-ICAM-1 (CD54) mAb in renal allograft recipient. Transplantation, 55(4), 766\u2013773.","journal-title":"Transplantation"},{"key":"72_CR51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.STR.27.4.709","volume":"27","author":"W. I. Rosenblum","year":"1996","unstructured":"Rosenblum, W. I., Nelson, G. H., Wormley, B., Werner, P., Wang, J., & Shih, C.Y. (1996). Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion\/aggregation over injured but not denuded endothelium in\u00a0vivo and ex vivo. Stroke, 27, 709\u2013711.","journal-title":"Stroke"},{"key":"72_CR52","first-page":"410","volume":"143","author":"T. Yamazald","year":"1993","unstructured":"Yamazald, T., Seko, Y., & Tamatani, T., et al. (1993). Expression of intracellular adhesion molecule-1 in rat heart with ischemia\/reperfusion and limitation of infarct size with antibodies against cell adhesion molecules. The American Journal of Pathology, 143, 410\u2013418.","journal-title":"The American Journal of Pathology"},{"key":"72_CR53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.81.1.226","volume":"81","author":"P. J. Simpson","year":"1990","unstructured":"Simpson, P. J., Todd, R. F., & Micelson, J. K., et al. (1990). sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alter leukocyte function. Circulation, 81, 226\u2013237.","journal-title":"Circulation"},{"key":"72_CR54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.150.2.644","volume":"150","author":"W. Newman","year":"1993","unstructured":"Newman, W., Dawson, B. L., & Carson, C. W., et al. (1993). Soluble E-selectins is found in supernatants of activated endothelial cells and is elevated in serum of patients with septic shock. Journal of Immunology, 150, 644\u2013654.","journal-title":"Journal of Immunology"},{"issue":"10","key":"72_CR55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0167-5699(93)90267-O","volume":"14","author":"A. J. H. Gearing","year":"1993","unstructured":"Gearing, A. J. H., & Newman, W. (1993). Circulating adhesion molecules in disease. Immunology Today, 14(10), 506\u2013512.","journal-title":"Immunology Today"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-007-0072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12033-007-0072-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-007-0072-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T19:48:35Z","timestamp":1684007315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12033-007-0072-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1007\/s12033-007-0072-7","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}